Literature DB >> 2711047

Rift Valley fever among domestic animals in the recent West African outbreak.

T G Ksiazek1, A Jouan, J M Meegan, B Le Guenno, M L Wilson, C J Peters, J P Digoutte, M Guillaud, N O Merzoug, E M Touray.   

Abstract

Severe haemorrhagic disease among the human population of the Senegal River Basin brought the Rift Valley fever virus (RVFV) outbreak of 1987 to the attention of science. As in previous RVFV outbreaks, local herdsmen reported a high incidence of abortion and disease in their livestock. Serum samples were obtained from domestic animal populations from areas near Rosso, the best studied focus of human infection, as well as other areas distant from known human disease. Among animals from the area of high incidence of human disease, antibody prevalence was as high as 85%, with approximately 80% of the sera positive for both RVFV IgG- and viral-specific IgM antibodies. In contrast, human populations in the same area had lower RVFV antibody prevalences, 40% or less, with 90% also being IgM-positive. Sera from livestock in coastal areas 280 km south of the epidemic area were negative for RVFV antibodies. Thus, the detection of RVFV specific IgG and IgM antibodies provided evidence of recent disease activity without the requirement to establish pre-disease antibody levels in populations or individuals and without viral isolation. Subsequently, detection of modest levels of IgG and IgM in the Ferlo region, 130 km south of the Senegal River flood plain, established that RVFV transmission also occurred in another area of the basin. Similar serological testing of domestic ungulates in The Gambia, 340 km south of Rosso, demonstrated antibody prevalence consistent with a lower level of recent transmission of RVFV, i.e., 24% IgG-positive with 6% of the positive sera also having RVFV-specific IgM.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2711047     DOI: 10.1016/s0923-2516(89)80086-x

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


  20 in total

1.  Risk assessment of the introduction of Rift Valley fever from the Horn of Africa to Yemen via legal trade of small ruminants.

Authors:  Shaif Abdo-Salem; Agnès Waret-Szkuta; François Roger; Marie-Marie Olive; Khalid Saeed; Véronique Chevalier
Journal:  Trop Anim Health Prod       Date:  2010-10-22       Impact factor: 1.559

2.  Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves.

Authors:  John C Morrill; Richard C Laughlin; Nandadeva Lokugamage; Jing Wu; Roberta Pugh; Pooja Kanani; L Garry Adams; Shinji Makino; C J Peters
Journal:  Vaccine       Date:  2013-08-27       Impact factor: 3.641

3.  Rift Valley fever virus epidemic in Kenya, 2006/2007: the entomologic investigations.

Authors:  Rosemary Sang; Elizabeth Kioko; Joel Lutomiah; Marion Warigia; Caroline Ochieng; Monica O'Guinn; John S Lee; Hellen Koka; Marvin Godsey; David Hoel; Hanafi Hanafi; Barry Miller; David Schnabel; Robert F Breiman; Jason Richardson
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

4.  Enzyme-linked immunosorbent assays for the detection of antibody to Crimean-Congo haemorrhagic fever virus in the sera of livestock and wild vertebrates.

Authors:  F J Burt; R Swanepoel; L E Braack
Journal:  Epidemiol Infect       Date:  1993-12       Impact factor: 2.451

5.  Severe Rift Valley fever may present with a characteristic clinical syndrome.

Authors:  Summerpal S Kahlon; Clarence J Peters; James Leduc; Eric M Muchiri; Samuel Muiruri; M Kariuki Njenga; Robert F Breiman; A Clinton White; Charles H King
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

6.  Cross-sectional survey of Rift Valley fever virus exposure in Bodhei village located in a transitional coastal forest habitat in Lamu county, Kenya.

Authors:  Samuel Muiruri; Ephantus W Kabiru; Eric M Muchiri; Hassan Hussein; Frederick Kagondu; A Desirée LaBeaud; Charles H King
Journal:  Am J Trop Med Hyg       Date:  2014-12-22       Impact factor: 2.345

7.  Rift Valley fever virus seroprevalence in human rural populations of Gabon.

Authors:  Xavier Pourrut; Dieudonné Nkoghé; Marc Souris; Christophe Paupy; Janusz Paweska; Cindy Padilla; Ghislain Moussavou; Eric M Leroy
Journal:  PLoS Negl Trop Dis       Date:  2010-07-27

8.  Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep.

Authors:  John C Morrill; Richard C Laughlin; Nandadeva Lokugamage; Roberta Pugh; Elena Sbrana; William J Weise; L Garry Adams; Shinji Makino; C J Peters
Journal:  Vaccine       Date:  2012-11-12       Impact factor: 3.641

9.  Multiple virus lineages sharing recent common ancestry were associated with a Large Rift Valley fever outbreak among livestock in Kenya during 2006-2007.

Authors:  Brian H Bird; Jane W K Githinji; Joseph M Macharia; Jacqueline L Kasiiti; Rees M Muriithi; Stephen G Gacheru; Joseph O Musaa; Jonathan S Towner; Serena A Reeder; Jennifer B Oliver; Thomas L Stevens; Bobbie R Erickson; Laura T Morgan; Marina L Khristova; Amy L Hartman; James A Comer; Pierre E Rollin; Thomas G Ksiazek; Stuart T Nichol
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

10.  Animal diseases affecting human welfare in developing countries: impacts and control.

Authors:  T M Yuill
Journal:  World J Microbiol Biotechnol       Date:  1991-03       Impact factor: 3.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.